Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Glaxo Wellcome's newest approach to ARDS

May 3, 1996

Arris announces preliminary results for APC-366

May 3, 1996

Rupatadine poised to enter phase II

May 3, 1996

New Glaxo Wellcome compounds protect against leukocyte-induced tissue damage

April 26, 1996

TAC-363 pharmacological profile presented

April 26, 1996

Merck Frosst's new generation of 5-LO inhibitors

April 26, 1996

Taisho's erythromycin A derivatives suppress IL-5 production

April 26, 1996

New antiasthmatic drugs patented by Fujirebio

April 26, 1996

Nikken Chemicals claims new antiasthmatic compounds

April 26, 1996

Update on terfenadine carboxylate progress

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...